Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LTU-904 PORTABLE LASER THERAPY UNIT

K-Number: K030295 · 2004-12-23

ApplicantRiancorp Pty, Ltd.
Decision Date2004-12-23
Product CodeNZY
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

LTU-904 PORTABLE LASER THERAPY UNIT is the device name listed in this FDA 510(k) record. The listed applicant is Riancorp Pty, Ltd.. It received FDA 510(k) clearance on 2004-12-23 under 510(k) number K030295. The device is classified under product code NZY. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LTU-904 PORTABLE LASER THERAPY UNIT?

LTU-904 PORTABLE LASER THERAPY UNIT is a medical device that received FDA 510(k) clearance on 2004-12-23. The listed applicant is Riancorp Pty, Ltd.. The 510(k) number is K030295.

When did LTU-904 PORTABLE LASER THERAPY UNIT receive FDA 510(k) clearance?

LTU-904 PORTABLE LASER THERAPY UNIT received FDA 510(k) clearance on 2004-12-23, under 510(k) number K030295.

Who is the listed applicant for LTU-904 PORTABLE LASER THERAPY UNIT?

The FDA 510(k) record lists Riancorp Pty, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LTU-904 PORTABLE LASER THERAPY UNIT?

The FDA product code for LTU-904 PORTABLE LASER THERAPY UNIT is NZY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑